Ben Inker, leader of GMO's asset allocation group, will take up the role of covering the broad investment outlook in the quarterly letters.
Unresolvable The public record could not settle it.
Promise: Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?
Said for an organisation they lead or work for; it counts on both records.
What would count as true or false
Promise with no stated deadline, implicitly starting with the quarterly letters following April 2012. True: Ben Inker went on to write the broad investment outlook section of GMO's quarterly letter, appearing as its author, alongside or after Grantham's letter, in quarterly letters from 2012 onward. Mostly true: he took up the role, but after a delay of one or two quarters or with a co-author. Mostly false: he wrote such an outlook only once or occasionally, while someone else regularly held the role. False: GMO quarterly letters after April 2012 show the outlook section regularly written by someone else, or a GMO announcement shows the plan was changed.
Set before the research began.
Evidence (5)
-
E1 Fed policy makes doing right by clients difficult InvestmentNews · 24 April 2012
“The following is excerpted from the quarterly commentary of Ben Inker, head of the Asset Allocation group for GMO LLC.”
-
E2 Is This Purgatory, Or Is It Hell? GMO · 2014 Own record
“Disclaimer: The views expressed are the views of Ben Inker through the period ending November 2014, and are subject to change at any time based on market and other conditions.”
-
E3 GMO Quarterly letter, Second Quarter 2014 GMO (hosted by Pensions & Investments conference site) · 2014 Own record
“Disclaimer: The views expressed are the views of Ben Inker through the period ending July 2014, and are subject to change at any time based on market and other conditions.”
-
E4 3Q 2017 GMO Quarterly Letter GMO · 2017 Own record
“What Happened to Inflation? And What Happens If It Comes Back? Ben Inker Pages 1-10”
-
E5 3Q 2017 GMO Quarterly Letter GMO · 2017 Own record
“Ben Inker. Mr. Inker is head of GMO’s Asset Allocation team and a member of the GMO Board of Directors.”
Reasoning
The evidence shows Inker writing GMO quarterly commentary in April 2012 [E1], with letters in 2Q and 3Q 2014 that carry his views [E2][E3] and an inflation piece in 3Q 2017 [E4]. It does not show that these were the broad investment outlook section, or that he held that role regularly, so the criteria cannot be settled.
Cite this claim
Jeremy Grantham, “Ben Inker, leader of GMO's asset allocation group, will take up the role of covering the broad investment outlook in the quarterly letters.” (said April 2012). Verdict: unresolvable. Reliability API, claim c_74446ec330b3, method 0.1.0+28da144b, dataset release v1.1.2. https://epistacklabs.com/claims/c_74446ec330b3
This claim is in dataset release v1.1.2, with the same verdict.
Reply to this claim
Verdicts are made automatically; how verdicts are made.